A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGA’s inventor and manufacturer have denied all liability in court.
California has enrolled into Medi-Cal more than 300,000 older immigrant adults lacking legal residency since May, but the state doesn’t know how many more might be eligible. Community workers are now searching for them.
Programs assisting people with dementia — and their caregivers — improve quality of life and care. But millions of unpaid family and friend caregivers may not know where or how to find help.
“What happens in Texas doesn’t stay in Texas,” warns an abortion rights advocate bracing for a district judge’s ruling on whether the abortion pill mifepristone was properly authorized by the FDA. His decision could force the medication off the U.S. market.
Lawmakers are considering creating standards to set Medicaid reimbursement rates. But industry observers wonder whether the move would be too little, too late to bolster a beleaguered industry.
Rather than simply reward top-performing facilities, the state’s Medicaid program will hand bonuses to nursing homes — even low-rated ones — for hiring more workers and reducing staff turnover.
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
The Senate’s top health committee focused on the worsening health care workforce shortage during its first hearing Thursday, with Sen. Bernie Sanders, its new chair, boldly promising bipartisan solutions.
Hundreds of physicians came to Washington this week to lobby Congress about their “recovery plan” for physicians, which includes a Medicare pay boost and an end to some frustrating insurance company requirements.